US FDA Could Be Facing Bolus Of Pandemic-Related Applications

 
• By Derrick Gingery
  
CDER's COVID-19 therapeutic workload is expected to increase with several clinical trials reading out.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Product Reviews

More from Pink Sheet